Aytu BioPharma, Inc. (AYTU) vs Rein Therapeutics Inc. (RNTX)
A side-by-side comparison of Aytu BioPharma, Inc. and Rein Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AYTU
Aytu BioPharma, Inc.
$2.06HealthcareDelayed quote: Oct 6, 2026, 12:48 PM EDT
RNTX
Rein Therapeutics Inc.
$0.82HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — AYTU vs RNTX
growth of $100 · dividends reinvested · last 2yAYTU +25.0% (+11.8%/yr)RNTX -61.1% (-37.6%/yr)AYTU compounded faster over this window
AYTU RNTX
AYTU vs RNTX: by the numbers
- •RNTX is the larger company ($23M vs $22M market cap).
- •Both run net losses; RNTX's is the smaller (0.00% vs -24.76% net margin).
Metrics side by side
Valuation
| Metric | AYTU | RNTX |
|---|---|---|
| P/S ratio | 0.38 | N/A |
| P/B ratio | 0.63 | 2.25 |
| FCF yield | 14.71% | N/A |
Profitability
| Metric | AYTU | RNTX |
|---|---|---|
| Gross margin | 63.95% | 0.00% |
| Operating margin | -14.44% | 0.00% |
| Net margin | -24.76% | 0.00% |
| ROE | -40.40% | -487.90% |
| ROIC | -14.21% | -36.89% |
Growth (annualized)
| Metric | AYTU | RNTX |
|---|---|---|
| Revenue CAGR (5Y) | -2.59% | N/A |
| Total return CAGR (5Y) | -48.14% | N/A |
Go deeper
Dig into the metrics
Aytu BioPharma ROERein Therapeutics ROEAytu BioPharma operating marginRein Therapeutics operating marginAytu BioPharma revenue growthRein Therapeutics revenue growthAytu BioPharma free cash flowRein Therapeutics free cash flow
Aytu BioPharma & Rein Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.